谷歌浏览器插件
订阅小程序
在清言上使用

New 1,4-Di-N-oxide-quinoxaline-2-ylmethylene Isonicotinic Acid Hydrazide Derivatives (VI) as anti-Mycobacterium tuberculosis Agents.

ChemInform(2011)

引用 71|浏览0
暂无评分
摘要
ChemInformVolume 42, Issue 45 Heterocyclic Compounds ChemInform Abstract: New 1,4-Di-N-oxide-quinoxaline-2-ylmethylene Isonicotinic Acid Hydrazide Derivatives (VI) as anti-Mycobacterium tuberculosis Agents. Enrique Torres, Enrique Torres Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorElsa Moreno, Elsa Moreno Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorSaioa Ancizu, Saioa Ancizu Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorCarlos Barea, Carlos Barea Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorSilvia Galiano, Silvia Galiano Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorIgnacio Aldana, Ignacio Aldana Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorAntonio Monge, Antonio Monge Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorSilvia Perez-Silanes, Silvia Perez-Silanes Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this author Enrique Torres, Enrique Torres Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorElsa Moreno, Elsa Moreno Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorSaioa Ancizu, Saioa Ancizu Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorCarlos Barea, Carlos Barea Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorSilvia Galiano, Silvia Galiano Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorIgnacio Aldana, Ignacio Aldana Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorAntonio Monge, Antonio Monge Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this authorSilvia Perez-Silanes, Silvia Perez-Silanes Cent. Invest. Farmacobiol. Apl., Univ. Navarra, E-31080 Pamplona, SpainSearch for more papers by this author First published: 13 October 2011 https://doi.org/10.1002/chin.201145160Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume42, Issue45November 8, 2011 RelatedInformation
更多
查看译文
关键词
Quinoxaline,Heterocyclic Compounds
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要